Diabetic Ketoacidosis (DKA) – A Comprehensive Medical Guide
Overview
Diabetic ketoacidosis (DKA) is an acute, life‑threatening metabolic complication of diabetes mellitus. It occurs when insulin levels are insufficient to allow glucose to enter cells, prompting the body to break down fat for energy. This process produces large amounts of acidic ketone bodies, leading to metabolic acidosis.
Who it affects: DKA is most common in people with type 1 diabetes, but it can also develop in individuals with type 2 diabetes, especially during severe stress, infection, or when insulin therapy is interrupted.
Prevalence: In the United States, DKA accounts for approximately 4–9 % of all hospital admissions among people with type 1 diabetes, translating to an estimated 30,000–40,000 hospitalizations per year. Worldwide, incidence varies, with higher rates reported in low‑resource settings where diabetes care is less accessible.[1] CDC, 2023
Symptoms
Symptoms develop over hours to days and can progress rapidly. The classic triad includes hyperglycemia, ketosis, and acidosis, but patients may present with a broader spectrum of signs.
- Polyuria (frequent urination) – Excess glucose pulls water into the urine.
- Polydipsia (excessive thirst) – Result of fluid loss.
- Weight loss – Due to fat breakdown.
- Abdominal pain – Ranges from mild cramping to severe pain mimicking an acute abdomen.
- Nausea & vomiting – Common early signs.
- Fatigue & weakness – Energy depletion.
- Rapid breathing (Kussmaul respirations) – Deep, labored breathing trying to blow off CO₂.
- Fruity‑smelling breath – Acetone odor.
- Confusion, lethargy, or altered mental status – Result of dehydration and acidosis.
- Dry mouth & skin turgor loss – Dehydration.
- Elevated heart rate (tachycardia) – Compensatory response.
In severe cases, seizures, coma, or shock can develop.
Causes and Risk Factors
Primary Mechanisms
- Insulin deficiency – Absolute (type 1) or relative (type 2) lack of insulin.
- Increased counter‑regulatory hormones – Glucagon, cortisol, catecholamines, and growth hormone raise blood glucose and promote lipolysis.
Common Triggers
- Missed or incorrect insulin doses
- Acute infection (e.g., pneumonia, urinary tract infection)
- Illness or surgery causing stress response
- Substance use – especially alcohol or illicit drugs (e.g., cocaine)
- New‑onset type 1 diabetes (often the first presentation)
- Pregnancy (especially in type 1 diabetics)
- Medications that increase glucose (e.g., corticosteroids, certain antipsychotics)
Risk Populations
- Young adults and adolescents with type 1 diabetes
- Individuals with poor adherence to insulin therapy
- Patients with limited access to diabetes education or supplies
- Those with psychiatric illness or substance use disorder
Diagnosis
DKA is a clinical diagnosis supported by laboratory data. Prompt recognition is critical.
Key Diagnostic Criteria (American Diabetes Association)
| Criterion | Typical Threshold |
|---|---|
| Blood glucose | >250 mg/dL (13.9 mmol/L) |
| Serum bicarbonate | < 18 mmol/L |
| Arterial pH | < 7.3 |
| Serum ketones | Positive (β‑hydroxybutyrate >3 mmol/L) |
| Anion gap | >12 mmol/L (elevated) |
Laboratory Tests
- Basic metabolic panel – Glucose, electrolytes, BUN/creatinine.
- Arterial blood gas (ABG) – Determines pH and CO₂.
- Serum β‑hydroxybutyrate – Most sensitive ketone assay.
- Urine ketones – Rapid bedside test, less specific.
- Complete blood count – Identifies infection.
- Serum osmolality – Helps assess dehydration severity.
Imaging (when indicated)
Chest X‑ray or abdominal CT may be ordered if there is suspicion of pneumonia, intra‑abdominal infection, or pancreatitis.
Treatment Options
Management centers on correcting the metabolic derangements while treating the underlying trigger.
Fluid Resuscitation
- Initial 0.9% saline 15‑20 mL/kg (≈1 L) over the first hour.
- Subsequent fluids adjusted based on CVP, urine output, and serum sodium.
- Switch to 0.45% saline when corrected sodium rises >145 mmol/L.
Insulin Therapy
- Continuous intravenous regular insulin infusion – 0.1 U/kg/hr after a 0.1 U/kg bolus (optional).
- Goal: Decrease glucose by 50‑70 mg/dL per hour and reduce ketones.
- When glucose reaches ~200 mg/dL, add dextrose (5%‑10% D5W) to prevent hypoglycemia while continuing insulin.
Electrolyte Management
- Potassium: Check before insulin; if <3.3 mmol/L, give 20‑30 mEq K⁺ before starting insulin. Target 4‑5 mmol/L during treatment.
- Sodium, phosphate, magnesium: Replace as needed based on labs.
Treat Underlying Cause
- Broad‑spectrum antibiotics for suspected infection.
- Holding or adjusting medications that raise glucose.
- Addressing precipitating events such as myocardial infarction or stroke.
Monitoring
Intensive care or high‑dependency unit setting is preferred.
- Glucose and electrolytes every 1‑2 hours until stable.
- Hourly urine output; target >0.5 mL/kg/hr.
- Frequent assessment of mental status and hemodynamics.
Transition to Subcutaneous Insulin
When acidosis resolves (pH >7.3, bicarbonate >15 mmol/L) and the patient can eat, transition to a basal‑bolus regimen with overlapping subcutaneous insulin for ~1‑2 hours to avoid rebound hyperglycemia.
Living with Diabetic Ketoacidosis
Even after recovery, preventing recurrence is a daily challenge. Below are practical tips.
Insulin Management
- Never skip or delay mealtime insulin; set alarms or use an insulin pump.
- Carry a “sick‑day” plan: increase basal insulin by 20‑30 % if unable to eat.
- Regularly review dosing with your diabetes care team.
Blood Glucose Monitoring
- Check at least four times daily (before meals, bedtime, and when ill).
- Use a continuous glucose monitor (CGM) if affordable; CGMs can alert to rapid rises.
Hydration & Nutrition
- Maintain adequate fluid intake, especially during illness or hot weather.
- Consume balanced meals with complex carbs, protein, and healthy fats.
- Avoid excessive sugary drinks; they can precipitate hyperglycemia.
Illness Management
- Follow a “sick‑day” protocol: check glucose & ketones every 4 hours.
- If ketones are ≥0.6 mmol/L (blood) or moderate/large (urine), contact your provider.
- Seek prompt medical care if vomiting prevents oral fluids.
Education & Support
- Attend diabetes self‑management education programs.
- Engage with support groups (online or local) for peer encouragement.
- Keep an updated emergency card listing “Type 1 Diabetes – Risk of DKA – Insulin needed.”
Prevention
Most DKA episodes are preventable with vigilant self‑care.
- Adherence to insulin regimens – Use reminders, pre‑filled pens, or pumps.
- Routine ketone testing when glucose >250 mg/dL or during illness.
- Regular follow‑up with endocrinology or primary care.
- Vaccinations (influenza, pneumococcal, COVID‑19) to reduce infection risk.[2] WHO, 2022
- Maintain a healthy weight and manage comorbidities (hypertension, dyslipidemia).
- Educate family, school, or workplace about signs of DKA.
Complications
If not treated promptly, DKA can progress to life‑threatening conditions.
- Severe dehydration and hypovolemic shock
- Electrolyte disturbances – especially hypokalemia, leading to arrhythmias.
- Cerebral edema – most common in children; presents with headache, papilledema, decreased consciousness.
- Acute kidney injury due to hypoperfusion.
- Thromboembolic events – hypercoagulable state in severe acidosis.
- Infection – DKA may mask underlying sepsis.
- Long‑term: recurrent DKA can impair quality of life and increase mortality risk.[3] Cleveland Clinic, 2023
When to Seek Emergency Care
- Blood glucose >250 mg/dL (13.9 mmol/L) with persistently high ketones (≥0.6 mmol/L blood or moderate/large urine).
- Rapid breathing (Kussmaul respirations) or a fruity/acetone odor on breath.
- Severe abdominal pain, vomiting, or inability to keep fluids down.
- Confusion, drowsiness, slurred speech, or any change in mental status.
- Persistent nausea, vomiting, or diarrhea causing dehydration.
- Chest pain, palpitations, or signs of a heart rhythm problem.
- Any sudden worsening after a recent illness, surgery, or missed insulin dose.
These signs can indicate progressing DKA, which requires rapid intravenous fluids, insulin, and close monitoring.
References
- Centers for Disease Control and Prevention. Diabetes Data & Statistics. 2023. https://www.cdc.gov/diabetes/library/features/diabetes-annual-report.html
- World Health Organization. Global Report on Diabetes. 2022. https://www.who.int/publications/i/item/9789241565257
- Cleveland Clinic. Diabetic Ketoacidosis (DKA) Treatment. Updated 2023. https://my.clevelandclinic.org/health/diseases/19789-diabetic-ketoacidosis-dka
- American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1‑S212.
- Mayo Clinic. Diabetic ketoacidosis. 2024. https://www.mayoclinic.org/diseases-conditions/diabetic-ketoacidosis/symptoms-causes/syc-20371551